Evidence map›Paper›PMID 35968047›Full record

ArticleCommunications medicine2022

Genomic surveillance of SARS-CoV-2 in Puerto Rico enabled early detection and tracking of variants.

Gilberto A Santiago, Betzabel Flores, Glenda L González, Keyla N Charriez, Limari Cora Huertas, Hannah R Volkman, Steven M Van Belleghem, Vanessa Rivera-Amill, Laura E Adams, Melissa Marzán and 6 more

Open access · goldAbstract read
In one paragraph

Article in Communications medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Gilberto A SantiagoCenters for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector Borne Diseases, Dengue Branch, San Juan, Puerto Rico.ORCID 0000-0002-8864-9503
Betzabel FloresCenters for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector Borne Diseases, Dengue Branch, San Juan, Puerto Rico.
Glenda L GonzálezCenters for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector Borne Diseases, Dengue Branch, San Juan, Puerto Rico.
Keyla N CharriezCenters for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector Borne Diseases, Dengue Branch, San Juan, Puerto Rico.
Limari Cora HuertasUniversity of Puerto Rico-Río Piedras, Department of Biology, Molecular Sciences and Research Center, San Juan, Puerto Rico.
Hannah R VolkmanCenters for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector Borne Diseases, Dengue Branch, San Juan, Puerto Rico.ORCID 0000-0001-7274-9641
Steven M Van BelleghemUniversity of Puerto Rico-Río Piedras, Department of Biology, Molecular Sciences and Research Center, San Juan, Puerto Rico.
Vanessa Rivera-AmillPonce Health Sciences University, Ponce Research Institute, Department of Basic Sciences, Ponce, Puerto Rico.
Laura E AdamsCenters for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector Borne Diseases, Dengue Branch, San Juan, Puerto Rico.
Melissa MarzánPuerto Rico Department of Health, Epidemiology Office, San Juan, Puerto Rico.
Lorena HernándezPuerto Rico Department of Health, Epidemiology Office, San Juan, Puerto Rico.
Iris CardonaPuerto Rico Department of Health, Epidemiology Office, San Juan, Puerto Rico.
Eduardo O'NeillCenters for Disease Control and Prevention, Office of Island Affairs, Center for State, Tribal, Local, and Territorial Support, Atlanta, GA USA.
Gabriela Paz-BaileyCenters for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector Borne Diseases, Dengue Branch, San Juan, Puerto Rico.
Riccardo PapaUniversity of Puerto Rico-Río Piedras, Department of Biology, Molecular Sciences and Research Center, San Juan, Puerto Rico.
Jorge L Muñoz-JordanCenters for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Division of Vector Borne Diseases, Dengue Branch, San Juan, Puerto Rico.
Centers for Disease Control and Prevention · USPuerto Rico Department of Health · PRUniversity of Puerto Rico at Río Piedras · PRPonce Health Sciences University · PR

Funding

The Role of Midbrain to Prelimbic Cortex Glutamatergic projections in Stress-induced Drug SeekingU54MD007579 · NIMHD · PONCE SCHOOL OF MEDICINE · PI Emmanuel Antonio Cruz, Kenira J Thompson · 2019 to 2026
$35.9M
Tracking and Evaluation CoreU54GM133807 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI PORTER, JAMES T. · 2020 to 2024
$17.7M
ACL HHS U01CK000580NCEZID CDC HHS U01 CK000580NIGMS NIH HHS U54 GM133807NIMHD NIH HHS U54 MD007579
6 · The paper itself

Abstract

Background: Puerto Rico has experienced the full impact of the COVID-19 pandemic. Since SARS-CoV-2, the virus that causes COVID-19, was first detected on the island in March of 2020, it spread rapidly though the island's population and became a critical threat to public health. Methods: We conducted a genomic surveillance study through a partnership with health agencies and academic institutions to understand the emergence and molecular epidemiology of the virus on the island. We sampled COVID-19 cases monthly over 19 months and sequenced a total of 753 SARS-CoV-2 genomes between March 2020 and September 2021 to reconstruct the local epidemic in a regional context using phylogenetic inference. Results: Our analyses reveal that multiple importation events propelled the emergence and spread of the virus throughout the study period, including the introduction and spread of most SARS-CoV-2 variants detected world-wide. Lineage turnover cycles through various phases of the local epidemic were observed, where the predominant lineage was replaced by the next competing lineage or variant after ~4 months of circulation locally. We also identified the emergence of lineage B.1.588, an autochthonous lineage that predominated in Puerto Rico from September to December 2020 and subsequently spread to the United States. Conclusions: The results of this collaborative approach highlight the importance of timely collection and analysis of SARS-CoV-2 genomic surveillance data to inform public health responses.

Indexed as

SARS virusViral infection

Identifiers

PMID35968047
PMCPMC9366129
OpenAlexW4290997257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.